Amundi
FLGT icon

Amundi’s Fulgent Genetics FLGT Stock Holding History

Amundi’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,596
Closed -$661K – 2110
2026
Q1 		$661K Buy
41,596
+6,072
+17% +$132K ﹤0.01% 1436
2025
Q4 		$933K Buy
+35,524
New +$922K ﹤0.01% 1287
2025
Q3 		– Sell
-34,268
Closed -$689K – 1621
2025
Q2 		$689K Sell
34,268
-48
-0.1% -$936 ﹤0.01% 1291
2025
Q1 		$583K Buy
34,316
+25,500
+289% +$434K ﹤0.01% 1458
2024
Q4 		$166K Buy
8,816
+5,199
+144% +$102K ﹤0.01% 1739
2024
Q3 		$74.3K Buy
3,617
+637
+21% +$14.2K ﹤0.01% 1805
2024
Q2 		$59.4K Sell
2,980
-1,295
-30% -$27K ﹤0.01% 1771
2024
Q1 		$86K Buy
4,275
+1,044
+32% +$25.9K ﹤0.01% 1786
2023
Q4 		$92.4K Sell
3,231
-1,099
-25% -$29.4K ﹤0.01% 1791
2023
Q3 		$108K Hold
4,330
– – ﹤0.01% 1742
2023
Q2 		$158K Buy
4,330
+2,532
+141% +$88.3K ﹤0.01% 1667
2023
Q1 		$55.5K Hold
1,798
– – ﹤0.01% 1870
2022
Q4 		$55.7K Sell
1,798
-78,000
-98% -$2.79M ﹤0.01% 1686
2022
Q3 		$3.06M Buy
+79,798
New +$4M ﹤0.01% 1075
2021
Q3 		– Sell
-45,300
Closed -$4.18M – 1588
2021
Q2 		$4.18M Buy
+45,300
New +$3.62M ﹤0.01% 1041

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Amundi's FLGT Position: Q2 2026 in Review

Amundi sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 41,596 shares — an estimated $661K sold.

Amundi first reported a position in FLGT in Q2 2021 and held it in 15 quarters. The position peaked at $4.18M in Q2 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Amundi reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Amundi sold 41,596 Fulgent Genetics shares in Q2 2026, an estimated $661K.
  • Amundi first reported a position in Fulgent Genetics in Q2 2021 and held it in 15 quarters.
  • Amundi's Fulgent Genetics position peaked at $4.18M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.